A new study led by Fred Hutch Cancer Center looked at zip codes to assess socioeconomic status and access to bone marrow transplants SAN DIEGO, Calif. — Dec. 8, 2024 — Patients with acute myeloid ...
1.5-year clinical outcomes in patients with triple-mutated AML who were positive and negative for MRD before allo-HSCT. This paper explores the clinical outcomes of allogeneic hematopoietic stem cell ...
Acute myeloid leukaemia (AML) is a complex and aggressive haematological malignancy that arises from the clonal proliferation of myeloid precursors. It is typified by a marked heterogeneity in ...
Although survival rates for acute myeloid leukemia (AML) continue to improve, many long-term survivors face persistent physical limitations, high rates of comorbidities, and suboptimal lifestyle ...
Patricia Ford, MD, a leader in bloodless medicine and transfusion-free oncology, discusses her career and how she became the ...
Upfront hematopoietic stem cell transplantation (HSCT) is more cost-effective than delayed HSCT for patients with intermediate-risk acute myeloid leukemia in remission, with higher incremental net ...
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. One important aspect of improving survival ...
Reply to: “Inappropriate Conclusions on Surrogate End Points in Early Breast Cancer Trials” and “Methodologic Considerations in Assessing Invasive Disease-Free Survival as a Surrogate End Point for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results